Overall, these findings confirm that NSCLC cells secrete large amounts of IL-6 by activating the IRE1α-XBP1s pathway, which reduces NKp30 surface expression on NK cells and impairs their function. This evidence concerns the gene NCR3 and non-small cell lung carcinoma.